Inspire Medical Systems (INSP) Gross Margin (2017 - 2026)

Inspire Medical Systems has disclosed Gross Margin across 10 years of filings, most recently posting 85.48% for Q2 2026.

• In Q2 2026, Gross Margin rose 145.0% year-over-year to 85.48%; the TTM figure through Jun 2026 stood at 86.13% (up 166.0% YoY), while the FY2025 annual figure was 85.39%, up 71.0% from the prior year.
• Gross Margin came in at 85.48% for Q2 2026 at Inspire Medical Systems, down from 86.47% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 86.59% in Q4 2025 to a low of 81.88% in Q3 2022.
• Average Gross Margin over 5 years is 84.76%, with a median of 84.76% recorded in 2024.
• Year-over-year, Gross Margin slumped 414 bps in 2022 and soared 222 bps in 2023.
• Over 5 years, Gross Margin stood at 83.94% in 2022, then increased by 2 bps to 85.43% in 2023, then retreated by 1 bps to 84.99% in 2024, then rose by 2 bps to 86.59% in 2025, then fell by 1 bps to 85.48% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 85.48% in Q2 2026, 86.47% in Q1 2026, and 86.59% in Q4 2025.